Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting No phase listed Observational

PHORA-USE Registry (PHORAR)

ClinicalTrials.gov ID: NCT07942012

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07942012. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 3:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pulmonary Hypertension Outcomes Risk Assessment Registry

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Pulmonary arterial hypertension (PAH) is a rare and progressive disease associated with significant illness and reduced survival. The PHORA-USE Registry (PHORAR) is a prospective, multicenter observational registry designed to collect real-world clinical data from adult and pediatric patients with PAH receiving routine clinical care. The purpose of this registry is to create a centralized database that can be used to better understand patient characteristics, treatment patterns, disease progression, and clinical outcomes. Information collected through the registry will support observational analyses aimed at identifying factors associated with outcomes and may contribute to the development of improved risk assessment and treatment strategies for patients with PAH.

Study identification

NCT ID
NCT07942012
Recruitment status
Not yet recruiting
Study type
Observational
Phase
Not listed
Enrollment
650 participants

Conditions and interventions

Eligibility (public fields only)

Age range
1 Day and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2027 (Estimated)
Primary completion
Jan 2031 (Estimated)
Completion
Jan 2031 (Estimated)
Last update posted
Nov 17, 2026

2027 – 2031

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Sentara Pulmonary Arterial Hypertension Clinic Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07942012, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2026 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.